Antitumor effects of metformin

Abstract

GUO Yan-Xun-；Ma-Shi-Yin. Antitumor effects of metformin[J]. Journal of International Oncology, 2015, 42(4): 281-283.

［1］ Lalau JD. Lactic acidosis induced by metformin: incidence, management and prevention［J］. Drug Saf, 2010, 33(9): 727740. ［2］ Zhang ZJ, Bi Y, Li S, et al. Reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and metaanalysis［J］. Am J Epidemiol, 2014, 180(1): 1114. ［3］ Chen WW, Shao YY, Shau WY, et al. The impact of diabetes mellitus on prognosis of early breast cancer in Asia［J］. Oncologist, 2012, 17(4): 485491. ［4］ Pollak MN. Investigating metformin for cancer prevention and treatment: the end of the beginning［J］. Cancer Discov, 2012, 2(9): 778790. ［5］ Alimova IN, Liu B, Fan Z, et al. Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro［J］. Cell Cycle, 2009, 8(6): 909915. ［6］ Deng XS, Wang S, Deng A, et al. Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triplenegative breast cancers［J］. Cell Cycle, 2012, 11(2): 367376. ［7］ Menendez JA, OliverasFerraros C, Cufi S, et al. Metformin is synthetically lethal with glucose withdrawal in cancer cells［J］. Cell Cycle, 2012, 11(15): 27822792. ［8］ Liu PP, Liao J, Tang ZJ, et al. Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway［J］. Cell Death Differ, 2014, 21(1): 124135. ［9］ Singh S, Singh PP, Singh AG, et al. Antidiabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and metaanalysis［J］. Am J Gastroenterol, 2013, 108(4): 510519. ［10］ Bao B, Wang Z, Ali S, et al. Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells［J］. Cancer Prev Res (Phila), 2012, 5(3): 355364. ［11］ Lonardo E, Cioffi M, Sancho P, et al. Metformin targets the metabolic achilles heel of human pancreatic cancer stem cells［J］. PLoS One, 2013, 8(10): e76518. ［12］ Gou S, Cui P, Li X, et al. Low concentrations of metformin selectively inhibit CD133+ cell proliferation in pancreatic cancer and have anticancer action［J］. PLoS One, 2013, 8(5): e63969. ［13］ Zhang T, Guo P, Zhang Y, et al. The antidiabetic drug metformin inhibits the proliferation of bladder cancer cells in vitro and in vivo［J］. Int J Mol Sci, 2013, 14(12): 2460324618. ［14］ Zhang ZJ, Zheng ZJ, Kan H, et al. Reduced risk of colorectal cancer with metformin therapy in patient with type 2 diabetes: a metaanalysis［J］. Diabetes Care, 2011, 34(10): 23232328. ［15］ Hosono K, Endo H, Takahashi H, et al. Metformin suppresses colorectal aberrant crypt foci in a shortterm clinical trial［J］. Cancer Prev Res(Phila), 2010, 3(9): 10771083. ［16］ Coco C, Zannoni GF, Caredda E, et al. Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients［J］. J Exp Clin Cancer Res, 2012, 31(1): 7181. ［17］ Feng YH, Wu CL, Shiau AL, et al. MicroRNA21mediated regulation of Sprouty2 protein expression enhances the cytotoxic effect of 5fluorouracil and metformin in colon cancer cells［J］. Int J Mol Med, 2012, 29(5): 920926. ［18］ Saito T, Chiba T, Yuki K, et al. Metformin, a diabetes drug, eliminates tumorinitiating hepatocellular carcinoma cells［J］. PLoS One, 2013, 8(7): e70010. ［19］ Chen H, Liu X, Chen H, et al. Role of SIRT1 and AMPK in mesenchymal stem cells differentiation［J］. Ageing Res Rev, 2014, 13: 5564. ［20］ Hadad S, Iwamoto T, Jordan L, et al. Evidence for biological effects of metformin in operable breast cancer: a preoperative, windowofopportunity, randomized trial［J］. Breast Cancer Res Treat, 2011, 128(3): 783794. ［21］ Lliopoulos D, Hirsch HA, Struhl K. Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types［J］. Cancer Res, 2011, 71(9): 31963201. ［22］ Lliopoulos D, Hirsch HA, Struhl K. Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types［J］. Cancer Res, 2011, 71(9): 31963201. ［23］张艳飞, 薛耀明, 江颖娟，等. 二甲双胍联合5氟尿嘧啶抑制人结肠癌细胞SW620生长的实验研究［J］. 实用医学杂志, 2013, 29(17): 27842786. ［24］ Xu W, Lin H, Zhang Y, et al. Compound Kushen injection suppresses human breast cancer stemlike cells by downregulating the canonical Wnt/betacatenin pathway［J］. J Exp Clin Cancer Res, 2011, 30(1): 103108. ［25］ Takatani T, Minagawa M, Takatani R, et al. AMP activated protein kinase attenuates Wnt/βcatenin signaling in human osteoblastic Saos2 cells［J］. Mol Cell Endocrinol, 2011, 339(12): 114119. ［26］ Zhang T, Wang X, He D. Metformin sensitizes human bladder cancer cells to TRAILinduced apoptosis through mTOR/S6K1mediated downregulation of cFLIP［J］. Anticancer Drugs, 2014, 25(8): 887897. ［27］ Zannella VE, Dal PA, Muaddi H, et al. Reprogramming metabolism with metformin improves tumor oxygenation and radiotherapy response［J］. Clin Cancer Res, 2013, 19(24): 67416750. ［28］ Li H, Chen X, Yu Y, et al. Metformin inhibits the growth of nasopharyngeal carcinoma cells and sensitizes the cells to radiation via inhibition of the DNA damage repair pathway［J］. Oncol Rep, 2014, 32(6): 25962604. ［29］ Storozhuk Y, Hopmans SN, Sanli T, et al. Metformin inhibits growth and enhances radiation response of nonsmall cell lung cancer (NSCLC) through ATM and AMPK［J］. Br J Cancer, 2013, 108(10): 20212032. ［30］ Bayraktar S, HernadezAya LF, Lei X, et al. Effect of metformin on survival outcomes in diabetic patients with triple receptornegative breast cancer［J］. Cancer, 2012, 118(5): 12021211.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297.

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments